E984-1279 Screening compound: 4-{2-methyl-5-oxo-4H,5H,6H,7H-pyrazolo[1,5-a]pyrimidin-4-yl}-N-[3-(piperidin-1-yl)propyl]butanamide

E984-1279 Screening compound: 4-{2-methyl-5-oxo-4H,5H,6H,7H-pyrazolo[1,5-a]pyrimidin-4-yl}-N-[3-(piperidin-1-yl)propyl]butanamide
E984-1279 Screening compound: 4-{2-methyl-5-oxo-4H,5H,6H,7H-pyrazolo[1,5-a]pyrimidin-4-yl}-N-[3-(piperidin-1-yl)propyl]butanamide alternative view

Chemical Structure Depiction of ChemDiv screening compound E984-1279
4-{2-methyl-5-oxo-4H,5H,6H,7H-pyrazolo[1,5-a]pyrimidin-4-yl}-N-[3-(piperidin-1-yl)propyl]butanamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

E984-1279

Molecular Formula

C19H31N5O2 (C19 H31 N5 O2)

Compound Name

4-{2-methyl-5-oxo-4H,5H,6H,7H-pyrazolo[1,5-a]pyrimidin-4-yl}-N-[3-(piperidin-1-yl)propyl]butanamide

IUPAC name

4-{2-methyl-5-oxo-4H5H6H7H-pyrazolo[15-a]pyrimidin-4-yl}-N-[3-(piperidin-1-yl)propyl]butanamide

SMILES

Cc1nn(CCC(N2CCCC(NCCCN3CCCCC3)=O)=O)c2c1

InChI

InChI=1S/C19H31N5O2/c1-16-15-18-23(19(26)8-14-24(18)21-16)13-5-7-17(25)20-9-6-12-22-10-3-2-4-11-22/h15H,2-14H2,1H3,(H,20,25)

InChI Key

LNGGOWSPLHHCJN-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14935998

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

361.49

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

-0.056

Distribution Coefficient, logD

-2.710

Water Solubility, LogSw

-1.19

Polar Surface Area

56.373

Acid Dissociation Constant (pKa)

15.52

Base Dissociation Constant (pKb)

10.05

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

73.70

E984-1279 in Drug Discovery

Included in Screening Libraries

3D-Diversity Natural-Product-Like Library (18102 compounds)

GPCR Targeted Library (31838 compounds)

Protein-Protein Interaction Library (218420 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Included in 1.7M Stock Database

Structure:
  • 3D
  • Cyclic compounds
Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands
  • PPI modulators

References: we are preparing a list of scientific research reports with E984-1279 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound E984-1279?
Check Price and Availability of E984-1279, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of E984-1279 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for E984-1279
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for E984-1279
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of E984-1279 available by request